查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1714862

胜肽合成市场按产品类型、技术、应用和最终用户划分－2025-2030 年全球预测

Peptide Synthesis Market by Product Type, Technology, Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2024 年胜肽合成市场价值估计为 7.6901 亿美元，预计 2025 年将成长至 8.2684 亿美元，复合年增长率为 7.84%，到 2030 年将达到 12.0984 亿美元。

主要市场统计数据
基准年2024年 7.6901亿美元
预计2025年 8.2684亿美元
预测年份 2030 1,209,840,000美元
复合年增长率（%） 7.84%

肽合成已成为现代科学技术的关键领域，是医学、诊断和研究进步的支柱。近年来，对精度和效率的不断增长的需求激发了技术创新，推动方法从传统技术转向尖端自动化系统。本摘要说明探讨了重塑该产业的当前趋势、技术突破和策略性细分市场。

不断发展的科学挑战，加上简化生产流程的需求，正在推动公司和研究机构采用更复杂的方法。随着新合成技术的开发和现有製程的改进，整个胜肽生产生态系统不断扩大。这种扩展支持广泛的应用，从早期发现研究到复杂治疗胜肽的生产。此外，最近在自动化和综合品管方面的投资建立了一个精确度和可扩展性相结合的框架，从而提高了可重复性和成本效益。

新格局的特点是学术界、工业界和技术提供者之间的合作，各自在推动产业发展方面发挥关键作用。了解这些动态对于必须应对监管挑战、技术整合和全球供应链复杂性的相关人员至关重要。在快速技术创新不断重塑产业的环境中，保持对不断变化的市场趋势的清晰观点不仅是一项策略决策，也是在日益动态的市场中保持竞争力的必要条件。

改变胜肽合成格局的变革

在过去的十年中，一场变革重新定义了胜肽合成领域，主要推动力是自动化程度的提高、品管技术的改进以及跨学科合作的加强。技术进步使得精确、快速且经济高效的合成过程成为可能，取代了许多传统方法，创造了以创新为基础的进步环境。

一个显着的变化是先进的机器人平台和电脑辅助流程的集成，这大大缩短了生产时间，同时最大限度地减少了人为错误。这些进步不仅提高了胜肽合成的准确性，而且还实现了规模化生产，满足了製药和生物技术製造的大规模需求。因此，该行业能够实现更高水平的一致性和可靠性，直接有助于加速治疗肽和候选疫苗的开发。

此外，溶液和固相合成方法结合的混合技术的使用越来越多，提供了更大的灵活性和效率。这一演变反映了整个产业致力于优化胜肽开发的每个阶段，从受体结合研究到复杂的药物发现过程。此外，不断发展的法律规范现在更倾向于强有力的品质保证协议和可追溯性的平台，为技术创新增添了新的动力。这些转型转变不仅为节省成本和永续性创造了机会，也为下一代研究创新铺平了道路，最终影响市场领导和相关人员的策略选择。

肽合成市场的关键细分洞察

肽合成市场具有多方面的细分策略，深入多个分析层面。在考虑产品类型细分时，市场会全面研究仪器、试剂、消耗品和服务。仪器分析更详细地关注层析法设备、冷冻干燥机和胜肽合成仪，它们在合成过程的效率和可靠性中都发挥着至关重要的作用。同时，透过胺基酸、耦合试剂、染料、萤光标记试剂和作为合成过程支柱的各种树脂等基本成分来仔细检查试剂和消耗品。

此外，基于技术的细分反映了市场理解的一个重要方面。透过评估混合技术、溶液相胜肽合成和固相胜肽合成等方法，我们确定了决定该领域创新速度和适用性的技术趋势。这种技术细分提供了宝贵的见解，说明不断发展的过程如何影响市场成长和业务效率。

除了硬体和技术组件之外，市场的应用细分还显示了诊断、调查和治疗等多种用途。每个应用都推动不同的需求模式和创新策略。此外，最终用户细分透过根据关键用户对市场进行分类提供了另一个方面。这包括推进基础科学的学术研究机构、参与诊断进步的临床实验室、促进合作计划的受託研究机构以及利用胜肽合成进行产品开发和商业化的製药和生物技术公司。这些细分洞察表明，市场多样化且充满活力，为创新、投资和成长提供了多种途径。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 对生物製药和胜肽类疗法的需求不断增加
      • 政府对生物製药研究的奖励和支持性法规结构
      • 全球生物技术和製药产业的扩张
    • 限制因素
      • 原料和合成试剂价格昂贵
    • 机会
      • 计算建模和胜肽设计的进步推动了创新治疗的发展
      • 扩大学术界和工业界的研发活动
    • 任务
      • 严格的法规结构和合规问题
  • 市场区隔分析
    • 产品类型：冷冻干燥设备对于保存生物活性的重要性日益增加
    • 应用：拓展胜肽合成在研究领域的应用
    • 技术：高胜肽产量和纯度增强了杂交和重组技术的潜力
    • 最终用户：製药和生物製药公司越来越多地使用胜肽合成进行药物研发
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社会
    • 技术的
    • 合法的
    • 环境

6. 胜肽合成市场（依产品类型）

  • 装置
    • 层析法设备
    • 冷冻干燥设备
    • 胜肽合成仪
  • 试剂和耗材
    • 胺基酸
    • 耦合试剂
    • 染料和萤光标记试剂
    • 树脂
  • 服务

第七章 胜肽合成市场（按技术）

  • 混合技术
  • 液相胜肽合成
  • 固相胜肽合成

第八章 胜肽合成市场（按应用）

  • 诊断
  • 调查
  • 治疗

第九章 胜肽合成市场（依最终用户）

  • 学术研究
  • 临床实验室
  • 合约研究组织
  • 製药和生物技术公司

第十章美洲胜肽合成市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

11. 亚太肽合成市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

12. 欧洲、中东和非洲胜肽合成市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争情境分析
  • 战略分析与建议

公司名单

  • 2B Scientific Limited
  • AAPPTec
  • ABclonal, Inc.
  • Advanced ChemTech
  • Almac Group Limited
  • AmbioPharm Inc.
  • AnaSpec Inc.
  • Bachem AG
  • Biocon Limited
  • BioDuro LLC
  • Biosynth Ltd.
  • Biotage
  • CEM Corporation
  • CPC Scientific Inc.
  • Creative Diagnostics
  • Creative Peptides
  • CSBio
  • Enamine Ltd.
  • GenScript Biotech Corporation
  • Gyros Protein Technologies AB
  • Hybio Pharmaceutical Co., Ltd.
  • JPT Peptide Technologies GmbH by TheraCode GmbH
  • Kaneka Corporation
  • LifeTein LLC
  • Merck KGaA
  • New England BioGroup, LLC
  • Novo Nordisk A/S
  • PolyPeptide Group AG
  • Thermo Fisher Scientific Inc.
  • USV Private Limited
Product Code: MRR-431388EE3B9B

The Peptide Synthesis Market was valued at USD 769.01 million in 2024 and is projected to grow to USD 826.84 million in 2025, with a CAGR of 7.84%, reaching USD 1,209.84 million by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 769.01 million
Estimated Year [2025] USD 826.84 million
Forecast Year [2030] USD 1,209.84 million
CAGR (%) 7.84%

Peptide synthesis has emerged as a critical area in modern science and technology, serving as a backbone for advances in pharmaceuticals, diagnostics, and research. In recent years, increasing demands for high precision and efficiency have catalyzed innovation, driving methodologies from traditional practices to state-of-the-art automated systems. This summary provides an in-depth look at current trends, technological breakthroughs, and strategic market segments that are reshaping the field.

A combination of evolving scientific challenges and the need for streamlined production processes has led companies and research institutions to adopt more sophisticated approaches. As new synthesis techniques are developed and existing processes refined, the overall ecosystem for peptide production continues to expand. This expansion supports a wide variety of applications ranging from early-stage discovery research to the production of complex therapeutic peptides. Furthermore, recent investments in automation and integrated quality control have established a framework where precision meets scalability, enabling enhanced reproducibility and cost efficiency.

The emerging landscape is characterized by collaboration between academia, industry, and technology providers, each playing a crucial role in driving the industry forward. Understanding these dynamics is essential for stakeholders who must navigate regulatory challenges, technological integration, and global supply chain complexities. In an environment where rapid innovation continuously reshapes the sector, maintaining a clear perspective on evolving market trends becomes not only a strategic decision but a necessity for staying competitive in an increasingly dynamic space.

Transformative Shifts Reshaping the Peptide Synthesis Landscape

Over the past decade, transformative shifts have redefined the landscape of peptide synthesis, driven primarily by enhanced automation, improved quality control techniques, and greater cross-disciplinary collaboration. Advances in technology have allowed for precise, rapid, and cost-effective synthesis processes that have replaced many conventional methods, fostering an environment in which innovation is the cornerstone of progress.

One notable shift has been the integration of sophisticated robotic platforms and computer-assisted processes that minimize human error while drastically reducing production time. These advancements have not only improved the accuracy of peptide synthesis but have also enabled scaled-up production to meet the demands of high-volume pharmaceutical and biotech manufacturing. As a result, industries are now capable of achieving higher levels of consistency and reliability, which directly contributes to the accelerated development of therapeutic peptides and vaccine candidates.

Additionally, the increasing use of hybrid technologies that combine both liquid and solid-phase synthesis methods has provided greater flexibility and efficiency. This evolution reflects an industry-wide commitment to optimizing every stage of peptide development, from receptor binding studies to complex drug discovery processes. Furthermore, evolving regulatory frameworks are now favoring platforms that demonstrate robust quality assurance protocols and traceability, adding another layer of impetus to technological reforms. These transformative shifts not only create opportunities for cost savings and improved sustainability but also pave the way for next-generation research innovations, ultimately influencing the strategic choices of market leaders and stakeholders alike.

Key Segmentation Insights in the Peptide Synthesis Market

The peptide synthesis market is characterized by a multifaceted segmentation strategy that delves into several layers of analysis. When examining product type segmentation, the market is comprehensively studied across equipment, reagents and consumables, as well as services. Equipment analysis is further detailed by focusing on chromatography equipment, lyophilizers, and peptide synthesizers, each playing a pivotal role in the efficiency and reliability of synthesis processes. In parallel, reagents and consumables are scrutinized through the lens of essential components like amino acids, coupling reagents, dyes and fluorescent labeling reagents, along with various resins that serve as the backbone of the synthetic process.

Furthermore, segmentation based on technology reflects a critical aspect of market understanding. By evaluating approaches such as hybrid technology, liquid phase peptide synthesis, and solid phase peptide synthesis, the analysis uncovers technological trends that define the innovation pace and adaptability within the sector. This technological segmentation offers valuable insights into how evolving processes are influencing market growth and operational efficiency.

Beyond hardware and technological components, the application segmentation of the market illustrates a diverse array of uses including diagnosis, research, and therapeutics. Each of these applications drives distinct demand patterns and innovation strategies. Additionally, end-user segmentation provides another dimension by categorizing the market based on primary users. This includes academic research entities that drive foundational science, clinical laboratories engaged indiagnostic advancements, contract research organizations that facilitate collaborative projects, and pharmaceutical and biotech companies that leverage peptide synthesis for product development and commercialization. Together, these segmentation insights reveal a market that is as diverse as it is dynamic, offering multiple avenues for innovation, investment, and growth.

Based on Product Type, market is studied across Equipment, Reagents & Consumables, and Services. The Equipment is further studied across Chromatography Equipment, Lyophilizers, and Peptide Synthesizers. The Reagents & Consumables is further studied across Amino Acids, Coupling Reagents, Dyes & Fluroscent Labeling Reagents, and Resins.

Based on Technology, market is studied across Hybrid Technology, Liquid Phase Peptide Synthesis, and Solid Phase Peptide Synthesis.

Based on Application, market is studied across Diagnosis, Research, and Therapeutics.

Based on End-User, market is studied across Academic Research, Clinical Laboratories, Contract Research Organizations, and Pharmaceutical & Biotech Companies.

Regional Insights Driving Market Dynamics

The global footprint of peptide synthesis is expansive, with regional distinctions that reveal unique market dynamics and localized growth opportunities. In regions such as the Americas, advanced research infrastructure and the robust presence of pharmaceutical giants have established a competitive marketplace, fostering rapid adoption of innovative synthesis technologies. Dynamic regulatory frameworks and a strong emphasis on research and development contribute significantly to the progressive landscape in this part of the world.

In Europe, the Middle East, and Africa, a combination of historical expertise in fine chemicals and growing investments in biotechnology is catalyzing transformative changes. The region is witnessing a steady expansion of collaborative projects, bolstered by governmental support for medical research and technology integration. Regulatory harmonization across various countries has streamlined processes, facilitating wider adoption of advanced peptide synthesis techniques.

Asia-Pacific represents another critical driver of market expansion, characterized by its accelerating pace of industrialization and a burgeoning scientific community. With increasing investments in research and state-of-the-art laboratories, this region is rapidly becoming a center for both technological advancements and large-scale production. The confluence of economic growth, favorable investment climates, and an expanding base of skilled professionals has set the stage for significant breakthroughs in peptide synthesis. These regional insights highlight distinct growth patterns and innovation drivers, underscoring the importance for market stakeholders to adopt region-specific strategies to capitalize on emerging opportunities.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Insights from Leading Industry Players

The competitive landscape in peptide synthesis is marked by the active participation of leading industry players, each contributing unique expertise and driving the overall momentum of the sector. Companies such as 2B Scientific Limited, AAPPTec, ABclonal, Inc., and Advanced ChemTech have steadily gained recognition for their contributions to groundbreaking research and innovative product development. These organizations leverage state-of-the-art technologies to optimize synthesis processes and deliver high-quality outcomes.

Other notable contributors include Almac Group Limited, AmbioPharm Inc., AnaSpec Inc., and Bachem AG, which have established themselves as trusted names in the field. Their commitment to integrating advanced methodologies with robust quality control mechanisms ensures that the supply chain remains resilient and adaptive to change. Entities such as Biocon Limited, BioDuro LLC, and Biosynth Ltd. have further enhanced the competitive landscape by focusing on specialized research and offering tailored solutions in peptide synthesis.

In addition, prominent names like Biotage, CEM Corporation, CPC Scientific Inc., and Creative Diagnostics have built a reputation on the consistent reliability of their equipment and reagents. Companies such as Creative Peptides, CSBio, and Enamine Ltd. are constantly pushing the boundaries of research innovation, interfacing technology with application-specific insights to drive market differentiation. GenScript Biotech Corporation, Gyros Protein Technologies AB, Hybio Pharmaceutical Co., Ltd., and JPT Peptide Technologies GmbH by TheraCode GmbH demonstrate a deep commitment to nurturing scientific excellence, while Kaneka Corporation, LifeTein LLC, Merck KGaA, and New England BioGroup, LLC influence market trends with their forward-thinking strategies. Additionally, Novo Nordisk A/S, PolyPeptide Group AG, Thermo Fisher Scientific Inc., and USV Private Limited round out a competitive field that continues to set benchmarks in quality, efficiency, and innovation in peptide synthesis. Collectively, these companies create a rich tapestry of expertise that drives both incremental improvements and disruptive changes across the industry.

The report delves into recent significant developments in the Peptide Synthesis Market, highlighting leading vendors and their innovative profiles. These include 2B Scientific Limited, AAPPTec, ABclonal, Inc., Advanced ChemTech, Almac Group Limited, AmbioPharm Inc., AnaSpec Inc., Bachem AG, Biocon Limited, BioDuro LLC, Biosynth Ltd., Biotage, CEM Corporation, CPC Scientific Inc., Creative Diagnostics, Creative Peptides, CSBio, Enamine Ltd., GenScript Biotech Corporation, Gyros Protein Technologies AB, Hybio Pharmaceutical Co., Ltd., JPT Peptide Technologies GmbH by TheraCode GmbH, Kaneka Corporation, LifeTein LLC, Merck KGaA, New England BioGroup, LLC, Novo Nordisk A/S, PolyPeptide Group AG, Thermo Fisher Scientific Inc., and USV Private Limited. Actionable Recommendations for Forward-Thinking Industry Leaders

Industry leaders must now consider a composite of strategic approaches in order to not only keep pace with ongoing innovation but to actively shape future trends in peptide synthesis. First and foremost, investing in advanced automation and integrating hybrid synthesis techniques can yield significant benefits. Companies that allocate resources toward cutting-edge machinery and data-driven quality control are poised to improve operational efficiency and reduce error margins. Decision-makers should also consider establishing robust partnerships across research institutions, technology providers, and regulatory bodies. Such collaborations facilitate the swift interchange of knowledge and best practices, allowing businesses to remain agile in the face of technological disruption.

In addition to technological investments, there is a critical need to adapt end-to-end processes to incorporate sustainable practices. As environmental concerns take center stage globally, adopting eco-friendly reagents, energy-efficient equipment, and waste reduction protocols will not only drive cost savings but also bolster a company's reputation in the market. Leaders should also focus on diversifying their product portfolios by exploring niche applications in diagnosis, research, and therapeutics. This deliberate diversification can serve as a buffer against market volatility, ensuring stable revenue streams under varying economic conditions.

With the rapidly evolving regulatory landscape, it is essential to stay ahead by investing in compliance and training programs. This proactive approach will help mitigate risks associated with new guidelines while reinforcing the reliability of synthesis outputs. By harnessing data analytics and embracing digital transformation, industry leaders can unlock actionable insights that inform long-term strategic planning. These recommendations are designed to empower decision-makers to not only respond to current challenges but also to set a robust foundation for sustainable growth and innovation in the peptide synthesis market.

Conclusion: Synthesis of Insights and Future Outlook

The evolving landscape of peptide synthesis presents numerous opportunities marked by technological innovation, regional dynamics, and competitive excellence. The insights drawn from product type and technology segmentations, coupled with a thorough understanding of market applications and end-user profiles, create a roadmap for strategic investment and operational enhancement. As regional markets mature and industry leaders consolidate their expertise, the path ahead is clear: adaptability and proactive innovation are key to thriving in this competitive arena.

In summary, the comprehensive analysis presented herein underscores the importance of marrying technology with strategy in a market that is both dynamic and transformative. This synthesis not only encapsulates current trends but also offers a vision for future growth and sustained success in the peptide synthesis market.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing demand for biopharmaceuticals and peptide-based therapeutics
      • 5.1.1.2. Government incentives and supportive regulatory frameworks for biopharma research
      • 5.1.1.3. Expansion of biotechnology and pharmaceutical sectors across globe
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of raw materials and expensive synthesis reagents
    • 5.1.3. Opportunities
      • 5.1.3.1. Advances in computational modeling and peptide design driving innovative therapeutic developments
      • 5.1.3.2. Expansion of research and development activities both in academia and industry
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory frameworks and compliance issues
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product Type: Rising significance of lyophilizers for maintaining bioactivity
    • 5.2.2. Application: Expanding application of peptide synthesis in research sector
    • 5.2.3. Technology: Rising potential of hybris & recombinant technology as it offers high peptide yield and purity
    • 5.2.4. End-User: Expanding usage of peptide synthesis by pharmaceutical & biopharmaceutical companies for drug discovery
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Peptide Synthesis Market, by Product Type

  • 6.1. Introduction
  • 6.2. Equipment
    • 6.2.1. Chromatography Equipment
    • 6.2.2. Lyophilizers
    • 6.2.3. Peptide Synthesizers
  • 6.3. Reagents & Consumables
    • 6.3.1. Amino Acids
    • 6.3.2. Coupling Reagents
    • 6.3.3. Dyes & Fluroscent Labeling Reagents
    • 6.3.4. Resins
  • 6.4. Services

7. Peptide Synthesis Market, by Technology

  • 7.1. Introduction
  • 7.2. Hybrid Technology
  • 7.3. Liquid Phase Peptide Synthesis
  • 7.4. Solid Phase Peptide Synthesis

8. Peptide Synthesis Market, by Application

  • 8.1. Introduction
  • 8.2. Diagnosis
  • 8.3. Research
  • 8.4. Therapeutics

9. Peptide Synthesis Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic Research
  • 9.3. Clinical Laboratories
  • 9.4. Contract Research Organizations
  • 9.5. Pharmaceutical & Biotech Companies

10. Americas Peptide Synthesis Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Peptide Synthesis Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Peptide Synthesis Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2024
  • 13.2. FPNV Positioning Matrix, 2024
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. BioDuro expands CRDMO capabilities with new automated solid-phase peptide synthesis scale-up facility in Shanghai
    • 13.3.2. PolyPeptide Group AG launches new large-scale SPPS facility in Braine-l'Alleud
    • 13.3.3. Cambrex unveils scalable and sustainable liquid-phase peptide synthesis technology
    • 13.3.4. Biosynth Extends Peptide Synthesis Offering With Pepceuticals Acquisition
    • 13.3.5. GenScript Expands Peptide Production Capabilities to Include Neoantigen Peptides and APIs
    • 13.3.6. Mesa Labs Acquires Belyntic's Peptide Purification Business
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 2B Scientific Limited
  • 2. AAPPTec
  • 3. ABclonal, Inc.
  • 4. Advanced ChemTech
  • 5. Almac Group Limited
  • 6. AmbioPharm Inc.
  • 7. AnaSpec Inc.
  • 8. Bachem AG
  • 9. Biocon Limited
  • 10. BioDuro LLC
  • 11. Biosynth Ltd.
  • 12. Biotage
  • 13. CEM Corporation
  • 14. CPC Scientific Inc.
  • 15. Creative Diagnostics
  • 16. Creative Peptides
  • 17. CSBio
  • 18. Enamine Ltd.
  • 19. GenScript Biotech Corporation
  • 20. Gyros Protein Technologies AB
  • 21. Hybio Pharmaceutical Co., Ltd.
  • 22. JPT Peptide Technologies GmbH by TheraCode GmbH
  • 23. Kaneka Corporation
  • 24. LifeTein LLC
  • 25. Merck KGaA
  • 26. New England BioGroup, LLC
  • 27. Novo Nordisk A/S
  • 28. PolyPeptide Group AG
  • 29. Thermo Fisher Scientific Inc.
  • 30. USV Private Limited

LIST OF FIGURES

  • FIGURE 1. PEPTIDE SYNTHESIS MARKET MULTI-CURRENCY
  • FIGURE 2. PEPTIDE SYNTHESIS MARKET MULTI-LANGUAGE
  • FIGURE 3. PEPTIDE SYNTHESIS MARKET RESEARCH PROCESS
  • FIGURE 4. PEPTIDE SYNTHESIS MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 17. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 19. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. PEPTIDE SYNTHESIS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 25. PEPTIDE SYNTHESIS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. PEPTIDE SYNTHESIS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PEPTIDE SYNTHESIS MARKET DYNAMICS
  • TABLE 7. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY CHROMATOGRAPHY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY LYOPHILIZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY PEPTIDE SYNTHESIZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY AMINO ACIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY COUPLING REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY DYES & FLUROSCENT LABELING REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY RESINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY HYBRID TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY LIQUID PHASE PEPTIDE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY SOLID PHASE PEPTIDE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. AUSTRALIA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 87. CHINA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 88. CHINA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. CHINA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 93. INDIA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. INDIA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. INDIA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 99. INDONESIA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 100. INDONESIA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. INDONESIA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 105. JAPAN PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. JAPAN PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. JAPAN PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 111. MALAYSIA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 112. MALAYSIA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. MALAYSIA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 118. PHILIPPINES PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 123. SINGAPORE PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 124. SINGAPORE PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SINGAPORE PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH KOREA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 135. TAIWAN PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 136. TAIWAN PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. TAIWAN PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 141. THAILAND PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 142. THAILAND PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. THAILAND PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 147. VIETNAM PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 148. VIETNAM PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. VIETNAM PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 160. DENMARK PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 161. DENMARK PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. DENMARK PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 166. EGYPT PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 167. EGYPT PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. EGYPT PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 172. FINLAND PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 173. FINLAND PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. FINLAND PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 178. FRANCE PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 179. FRANCE PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. FRANCE PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 184. GERMANY PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 185. GERMANY PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. GERMANY PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 190. ISRAEL PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 191. ISRAEL PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. ISRAEL PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 196. ITALY PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 197. ITALY PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 198. ITALY PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 202. NETHERLANDS PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. NETHERLANDS PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 208. NIGERIA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 209. NIGERIA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 210. NIGERIA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 214. NORWAY PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 215. NORWAY PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 216. NORWAY PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 220. POLAND PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 221. POLAND PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 222. POLAND PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 226. QATAR PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 227. QATAR PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 228. QATAR PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 232. RUSSIA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 233. RUSSIA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 234. RUSSIA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 238. SAUDI ARABIA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 240. SAUDI ARABIA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 246. SOUTH AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 250. SPAIN PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 251. SPAIN PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 252. SPAIN PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 256. SWEDEN PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 257. SWEDEN PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 258. SWEDEN PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 262. SWITZERLAND PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 264. SWITZERLAND PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 268. TURKEY PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 269. TURKEY PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 270. TURKEY PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED KINGDOM PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 282. UNITED KINGDOM PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 283. PEPTIDE SYNTHESIS MARKET SHARE, BY KEY PLAYER, 2024
  • TABLE 284. PEPTIDE SYNTHESIS MARKET, FPNV POSITIONING MATRIX, 2024